Candriam S.C.A. Arrowhead Pharmaceuticals, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$27.21 - $39.48 $1.17 Million - $1.7 Million	43,000 Added 23.24%	228,054 $6.52 Million
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $742,000 - $1.09 Million	-35,000 Reduced 15.91%	185,054 $5.66 Million
Q2 2023 Aug 08, 2023	SELL	$25.16 - $41.38 $1.71 Million - $2.81 Million	-68,000 Reduced 23.61%	220,054 $7.85 Million
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $1.66 Million - $2.7 Million	-70,000 Reduced 19.55%	288,054 $7.32 Million
Q4 2022 Feb 13, 2023	SELL	$28.0 - $40.56 $2.52 Million - $3.65 Million	-90,000 Reduced 20.09%	358,054 $14.5 Million
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $2.04 Million - $3.32 Million	68,689 Added 18.11%	448,054 $14.8 Million
Q2 2022 Aug 03, 2022	BUY	$27.79 - $50.61 $3.04 Million - $5.53 Million	109,311 Added 40.48%	379,365 $13.4 Million
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $8.35 Million - $14.8 Million	210,867 Added 356.27%	270,054 $12.4 Million
Q4 2021 Feb 10, 2022	SELL	$58.09 - $82.51 $7.97 Million - $11.3 Million	-137,221 Reduced 69.87%	59,187 $3.92 Million
Q2 2021 Jul 20, 2021	BUY	$62.15 - $90.32 $2.02 Million - $2.93 Million	32,450 Added 19.79%	196,408 $16.3 Million
Q4 2020 Jan 22, 2021	SELL	$43.82 - $85.37 $4.7 Million - $9.15 Million	-107,188 Reduced 39.53%	163,958 $12.6 Million
Q3 2020 Oct 19, 2020	SELL	$33.21 - $51.27 $1.66 Million - $2.56 Million	-50,000 Reduced 15.57%	271,146 $11.7 Million
Q2 2020 Jul 23, 2020	BUY	$26.12 - $43.27 $1.01 Million - $1.67 Million	38,638 Added 13.68%	321,146 $13.9 Million
Q4 2019 Jan 21, 2020	SELL	$28.14 - $73.01 $14.1 Million - $36.6 Million	-501,492 Reduced 63.97%	282,508 $18,000
Q3 2019 Oct 21, 2019	BUY	$26.26 - $34.86 $6.7 Million - $8.89 Million	255,000 Added 48.2%	784,000 $22,000
Q2 2019 Aug 01, 2019	SELL	$17.43 - $28.82 $1.13 Million - $1.87 Million	-65,000 Reduced 10.94%	529,000 $14 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $859,200 - $1.58 Million	80,000 Added 15.56%	594,000 $7.38 Million
Q3 2018 Nov 07, 2018	BUY	$14.0 - $20.3 $7.2 Million - $10.4 Million	514,000 New	514,000 $9.85 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account